19.02.2013 Views

Reviews in Computational Chemistry Volume 18

Reviews in Computational Chemistry Volume 18

Reviews in Computational Chemistry Volume 18

SHOW MORE
SHOW LESS
  • No tags were found...

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

Application of Scor<strong>in</strong>g Functions <strong>in</strong> Virtual Screen<strong>in</strong>g 69<br />

when docked <strong>in</strong>to the agonist structure, but more importantly, about half of<br />

the agonists are also among the 10% top ranked molecules <strong>in</strong> the database<br />

when docked <strong>in</strong>to the open, antagonist structure, where they have to compete<br />

with many structures form<strong>in</strong>g salt bridges.<br />

F<strong>in</strong>d<strong>in</strong>g Weak Inhibitors<br />

Seed<strong>in</strong>g experiments are often carried out with a handful of active compounds<br />

that have already been optimized for b<strong>in</strong>d<strong>in</strong>g to a given target. Enrichment<br />

factors achieved <strong>in</strong> this way are often mislead<strong>in</strong>g, because f<strong>in</strong>d<strong>in</strong>g potent<br />

<strong>in</strong>hibitors from among a number of random molecules is significantly easier<br />

than dist<strong>in</strong>guish<strong>in</strong>g weakly b<strong>in</strong>d<strong>in</strong>g <strong>in</strong>hibitors from nonb<strong>in</strong>ders. In practice,<br />

virtual screen<strong>in</strong>g will f<strong>in</strong>d, at best, <strong>in</strong>hibitors <strong>in</strong> the low micromolar range,<br />

simply because no chemical database will be large enough, diverse enough,<br />

and lucky enough to f<strong>in</strong>d optimized leads right away.<br />

The difficulties associated with weak b<strong>in</strong>ders are illustrated <strong>in</strong> Figure 7<br />

with thromb<strong>in</strong> as a target. The 7500 compound subset of the WDI mentioned<br />

above was docked <strong>in</strong>to the thromb<strong>in</strong> active site together with three sets of 100<br />

100<br />

90<br />

80<br />

70<br />

60<br />

50<br />

<strong>in</strong>hibitors with pK i 7-9<br />

<strong>in</strong>hibitors with pK i 5-7<br />

<strong>in</strong>hibitors with pK i 4-5<br />

40<br />

1 2 3 4 5 10 20 30 50 100<br />

Figure 7 Enrichment of three sets of 100 thromb<strong>in</strong> <strong>in</strong>hibitors that cover different ranges<br />

of activity. Less active compounds are more difficult to enrich.

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!